Regional Analysis

Global Cordyceps Sinensis and Militaris Extract Market – Regional Analysis

On the basis of region, the global Cordyceps Sinensis and Militaris Extract market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to be the most lucrative region in the global Cordyceps Sinensis and Militaris Extract market, owing to increasing product launches by the market players is expected to foster the regional market growth over the forecast period. For instance, in April 2021, Shroomshot, a company that manufactures organic products and is based in California, U.S., had launched its third functional mushroom blend Inner Energy, which is made with 1,000 mg of freshly harvested and extracted organic cordyceps mushroom fruiting bodies.

Europe is expected to hold a major market share in the global Cordyceps Sinensis and Militaris Extract market, owing to increasing initiatives by market players to develop medicinal products by utilizing key ingredients isolated from cordyceps For instance, in July 2019, NuCana, a U.K.-based clinical-stage biopharmaceutical company focused on significantly improving survival outcomes for patients with cancer, initiated phase 1 clinical study (NUC-7738) on ProTide transformation of cordycepin (NuTide:701 - nucleoside analog) to evaluate its safety and efficiency in the treatment of advanced solid tumors and hematological malignancies.

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa